Insights

Patient Centered Trials AtaiBeckley collaborates with PsyPAN to integrate lived trial participant experiences, signaling a strong demand for partners that optimize patient recruitment, retention, and experience in psychedelic and mental health research.

Rapid Acting Therapies The focus on rapid-acting, durable, and convenient mental health treatments for treatment-resistant depression and social anxiety creates opportunities to co-develop digital tools, data capture measures, and payer strategies to accelerate patient access.

CRO and Vendors As a clinical-stage company pursuing multiple programs, there is strong need for CROs, site networks, and data analytics partners to accelerate trials and support regulatory readiness.

Digital Engagement With a digital tech stack centered on LinkedIn insights, Next.js, Vercel, and security tools, there are opportunities to offer marketing analytics, website optimization, and patient recruitment platforms that boost trial enrollment and brand reach.

Investor Relations Growth Recent leadership changes and ongoing investor activity indicate a need for scalable investor relations support, financial systems integration, and communications services to attract and inform a growing investor base.

Similar companies to AtaiBeckley

AtaiBeckley Tech Stack

AtaiBeckley uses 8 technology products and services including Vercel Analytics, Linkedin Insight Tag, React, and more. Explore AtaiBeckley's tech stack below.

  • Vercel Analytics
    Analytics
  • Linkedin Insight Tag
    Analytics
  • React
    Javascript Frameworks
  • Priority Hints
    Performance
  • Vercel
    Platform As A Service
  • Smartsheet
    Project Management
  • Tailwind CSS
    UI Frameworks
  • shadcn/ui
    UI Frameworks

Media & News

AtaiBeckley's Email Address Formats

AtaiBeckley uses at least 2 format(s):
AtaiBeckley Email FormatsExamplePercentage
First@atai.lifeJohn@atai.life
60%
First.Last@atai.lifeJohn.Doe@atai.life
33%
Last@atai.lifeDoe@atai.life
6%
First.L@atai.lifeJohn.D@atai.life
1%

Frequently Asked Questions

What is AtaiBeckley's stock symbol?

Minus sign iconPlus sign icon
AtaiBeckley is a publicly traded company; the company's stock symbol is ATAI.

What is AtaiBeckley's official website and social media links?

Minus sign iconPlus sign icon
AtaiBeckley's official website is ataibeckley.com and has social profiles on LinkedInCrunchbase.

What is AtaiBeckley's SIC code NAICS code?

Minus sign iconPlus sign icon
AtaiBeckley's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AtaiBeckley have currently?

Minus sign iconPlus sign icon
As of July 2026, AtaiBeckley has approximately 100 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Cao/Cfo/Vp/Controller: A. J.Chief Medical Officer: K. C.Chief Research & Development Officer: R. C.. Explore AtaiBeckley's employee directory with LeadIQ.

What industry does AtaiBeckley belong to?

Minus sign iconPlus sign icon
AtaiBeckley operates in the Biotechnology Research industry.

What technology does AtaiBeckley use?

Minus sign iconPlus sign icon
AtaiBeckley's tech stack includes Vercel AnalyticsLinkedin Insight TagReactPriority HintsVercelSmartsheetTailwind CSSshadcn/ui.

What is AtaiBeckley's email format?

Minus sign iconPlus sign icon
AtaiBeckley's email format typically follows the pattern of First@atai.life. Find more AtaiBeckley email formats with LeadIQ.

How much funding has AtaiBeckley raised to date?

Minus sign iconPlus sign icon
As of July 2026, AtaiBeckley has raised $796M in funding. The last funding round occurred on Oct 16, 2025.

When was AtaiBeckley founded?

Minus sign iconPlus sign icon
AtaiBeckley was founded in 2018.
AtaiBeckley logo

AtaiBeckley

Biotechnology ResearchNew York, United States51-200 Employees

AtaiBeckley is a clinical-stage biotechnology company based in New York City that aims to advance mental health care by developing treatments that act quickly, last, and are convenient to use. Operating in the biotechnology research industry, it is positioned as a mid-sized firm focused on clinical development.

The company arose in 2025 from the combination of atai Life Sciences and Beckley Psytech. Its clinical-stage programs target mental health conditions with significant unmet needs, including treatment-resistant depression and social anxiety disorder. In recent months, the company has been active in industry collaborations and investor forums, and has engaged in partnerships intended to incorporate patient perspectives into research.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
ATAI
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $796M

    AtaiBeckley has raised a total of $796M of funding over 15 rounds. Their latest funding round was raised on Oct 16, 2025as a post_ipo_equity.

  • $25M$50M

    AtaiBeckley's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $796M

    AtaiBeckley has raised a total of $796M of funding over 15 rounds. Their latest funding round was raised on Oct 16, 2025as a post_ipo_equity.

  • $25M$50M

    AtaiBeckley's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.